1Kril MG.Docetaxel:emerging options in the management of non-small-cell lung cancer[J].Onconlogy,1997,11(7):9.
2Fossella FV,Lee JS,Shin DM,et al.PhaseⅡstudy of docetaxel foradvanced or metastatic platinum-refractory non-small-cell lungcancer[J].J Clin Oncol,1995,13(3):645.
3李家泰.临床药理学[M]第2版[M].北京:人民卫生出版社,1997.1034-1037.
4Shepherd FA,Dancey J,Ramlau R,et al.Prospective randomizedtrial of docetaxel versus best supportive care previously treated withplatinum-based chemotherapy[J].J Clin Oncol,2000,18(10):2095.
7Sharma A,Mayhew E,Boticsak L. Activity of paclitaxel liposome formulations against human ovarian tumor xenografts[J].International Journal of C ancer,2012,10(01 ): 103-107.
